 | • レポートコード：GIR-107A14329 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、84ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、リラグルチド注射のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。リラグルチド注射の種類別市場規模（成人2型糖尿病、II型）、用途別市場規模（病院、クリニック）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・リラグルチド注射の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Novo Nordisk ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：成人2型糖尿病、II型 ・用途別分析2016年-2026年：病院、クリニック ・リラグルチド注射の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・リラグルチド注射のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・リラグルチド注射のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・リラグルチド注射の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・リラグルチド注射の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Liraglutide Injection market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Liraglutide Injection size is estimated to be xx million in 2021 from USD xx million in 2020, with a change of XX% between 2020 and 2021. The global Liraglutide Injection market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Liraglutide Injection market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Adult Type 2 Diabetes
Type II
Market segment by Application can be divided into
Hospital
Clinic
The key market players for global Liraglutide Injection market are listed below:
Novo Nordisk
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Liraglutide Injection product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Liraglutide Injection, with price, sales, revenue and global market share of Liraglutide Injection from 2019 to 2021.
Chapter 3, the Liraglutide Injection competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Liraglutide Injection breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Liraglutide Injection market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Liraglutide Injection sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Liraglutide Injection Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Liraglutide Injection Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Adult Type 2 Diabetes
1.2.3 Type II
1.3 Market Analysis by Application
1.3.1 Overview: Global Liraglutide Injection Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Hospital
1.3.3 Clinic
1.4 Global Liraglutide Injection Market Size & Forecast
1.4.1 Global Liraglutide Injection Sales in Value (2016-2026))
1.4.2 Global Liraglutide Injection Sales in Volume (2016-2026)
1.4.3 Global Liraglutide Injection Price by Type (2016-2026) & (USD/Pcs)
1.5 Global Liraglutide Injection Production Capacity Analysis
1.5.1 Global Liraglutide Injection Total Production Capacity (2016-2026)
1.5.2 Global Liraglutide Injection Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Liraglutide Injection Market Drivers
1.6.2 Liraglutide Injection Market Restraints
1.6.3 Liraglutide Injection Trends Analysis
2 Manufacturers Profiles
2.1 Novo Nordisk
2.1.1 Novo Nordisk Details
2.1.2 Novo Nordisk Major Business
2.1.3 Novo Nordisk Liraglutide Injection Product and Services
2.1.4 Novo Nordisk Liraglutide Injection Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Liraglutide Injection Sales by Manufacturer
3.1 Global Liraglutide Injection Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Liraglutide Injection Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Liraglutide Injection
3.4 Market Concentration Rate
3.4.1 Top 3 Liraglutide Injection Manufacturer Market Share
3.4.2 Top 6 Liraglutide Injection Manufacturer Market Share
3.5 Global Liraglutide Injection Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Liraglutide Injection Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Liraglutide Injection Market Size by Region
4.1.1 Global Liraglutide Injection Sales in Volume by Region (2016-2026)
4.1.2 Global Liraglutide Injection Revenue by Region (2016-2026)
4.2 North America Liraglutide Injection Revenue (2016-2026)
4.3 Europe Liraglutide Injection Revenue (2016-2026)
4.4 Asia-Pacific Liraglutide Injection Revenue (2016-2026)
4.5 South America Liraglutide Injection Revenue (2016-2026)
4.6 Middle East and Africa Liraglutide Injection Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Liraglutide Injection Sales in Volume by Type (2016-2026)
5.2 Global Liraglutide Injection Revenue by Type (2016-2026)
5.3 Global Liraglutide Injection Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Liraglutide Injection Sales in Volume by Application (2016-2026)
6.2 Global Liraglutide Injection Revenue by Application (2016-2026)
6.3 Global Liraglutide Injection Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Liraglutide Injection Sales by Type (2016-2026)
7.2 North America Liraglutide Injection Sales by Application (2016-2026)
7.3 North America Liraglutide Injection Market Size by Country
7.3.1 North America Liraglutide Injection Sales in Volume by Country (2016-2026)
7.3.2 North America Liraglutide Injection Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Liraglutide Injection Sales by Type (2016-2026)
8.2 Europe Liraglutide Injection Sales by Application (2016-2026)
8.3 Europe Liraglutide Injection Market Size by Country
8.3.1 Europe Liraglutide Injection Sales in Volume by Country (2016-2026)
8.3.2 Europe Liraglutide Injection Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Liraglutide Injection Sales by Type (2016-2026)
9.2 Asia-Pacific Liraglutide Injection Sales by Application (2016-2026)
9.3 Asia-Pacific Liraglutide Injection Market Size by Region
9.3.1 Asia-Pacific Liraglutide Injection Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Liraglutide Injection Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Liraglutide Injection Sales by Type (2016-2026)
10.2 South America Liraglutide Injection Sales by Application (2016-2026)
10.3 South America Liraglutide Injection Market Size by Country
10.3.1 South America Liraglutide Injection Sales in Volume by Country (2016-2026)
10.3.2 South America Liraglutide Injection Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Liraglutide Injection Sales by Type (2016-2026)
11.2 Middle East & Africa Liraglutide Injection Sales by Application (2016-2026)
11.3 Middle East & Africa Liraglutide Injection Market Size by Country
11.3.1 Middle East & Africa Liraglutide Injection Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Liraglutide Injection Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Liraglutide Injection Typical Distributors
12.3 Liraglutide Injection Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Liraglutide Injection Revenue by Type, (USD Million), 2021-2026
Table 2. Global Liraglutide Injection Revenue by Application, (USD Million), 2021-2026
Table 3. Novo Nordisk Basic Information, Manufacturing Base and Competitors
Table 4. Novo Nordisk Major Business
Table 5. Novo Nordisk Liraglutide Injection Product and Services
Table 6. Novo Nordisk Liraglutide Injection Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Global Liraglutide Injection Sales by Manufacturer (2019-2021e) & (K Pcs)
Table 8. Global Liraglutide Injection Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 9. Market Position of Manufacturers in Liraglutide Injection, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 10. Global Liraglutide Injection Production Capacity by Company, (K Pcs): 2020 VS 2021
Table 11. Head Office and Liraglutide Injection Production Site of Key Manufacturer
Table 12. Liraglutide Injection New Entrant and Capacity Expansion Plans
Table 13. Liraglutide Injection Mergers & Acquisitions in the Past Five Years
Table 14. Global Liraglutide Injection Sales by Region (2016-2021e) & (K Pcs)
Table 15. Global Liraglutide Injection Sales by Region (2021-2026) & (K Pcs)
Table 16. Global Liraglutide Injection Revenue by Region (2016-2021e) & (USD Million)
Table 17. Global Liraglutide Injection Revenue by Region (2021-2026) & (USD Million)
Table 18. Global Liraglutide Injection Sales by Type (2016-2021e) & (K Pcs)
Table 19. Global Liraglutide Injection Sales by Type (2021-2026) & (K Pcs)
Table 20. Global Liraglutide Injection Revenue by Type (2016-2021e) & (USD Million)
Table 21. Global Liraglutide Injection Revenue by Type (2021-2026) & (USD Million)
Table 22. Global Liraglutide Injection Price by Type (2016-2021e) & (USD/Pcs)
Table 23. Global Liraglutide Injection Price by Type (2021-2026) & (USD/Pcs)
Table 24. Global Liraglutide Injection Sales by Application (2016-2021e) & (K Pcs)
Table 25. Global Liraglutide Injection Sales by Application (2021-2026) & (K Pcs)
Table 26. Global Liraglutide Injection Revenue by Application (2016-2021e) & (USD Million)
Table 27. Global Liraglutide Injection Revenue by Application (2021-2026) & (USD Million)
Table 28. Global Liraglutide Injection Price by Application (2016-2021e) & (USD/Pcs)
Table 29. Global Liraglutide Injection Price by Application (2021-2026) & (USD/Pcs)
Table 30. North America Liraglutide Injection Sales by Country (2016-2021e) & (K Pcs)
Table 31. North America Liraglutide Injection Sales by Country (2021-2026) & (K Pcs)
Table 32. North America Liraglutide Injection Revenue by Country (2016-2021e) & (USD Million)
Table 33. North America Liraglutide Injection Revenue by Country (2021-2026) & (USD Million)
Table 34. North America Liraglutide Injection Sales by Type (2016-2021e) & (K Pcs)
Table 35. North America Liraglutide Injection Sales by Type (2021-2026) & (K Pcs)
Table 36. North America Liraglutide Injection Sales by Application (2016-2021e) & (K Pcs)
Table 37. North America Liraglutide Injection Sales by Application (2021-2026) & (K Pcs)
Table 38. Europe Liraglutide Injection Sales by Country (2016-2021e) & (K Pcs)
Table 39. Europe Liraglutide Injection Sales by Country (2021-2026) & (K Pcs)
Table 40. Europe Liraglutide Injection Revenue by Country (2016-2021e) & (USD Million)
Table 41. Europe Liraglutide Injection Revenue by Country (2021-2026) & (USD Million)
Table 42. Europe Liraglutide Injection Sales by Type (2016-2021e) & (K Pcs)
Table 43. Europe Liraglutide Injection Sales by Type (2021-2026) & (K Pcs)
Table 44. Europe Liraglutide Injection Sales by Application (2016-2021e) & (K Pcs)
Table 45. Europe Liraglutide Injection Sales by Application (2021-2026) & (K Pcs)
Table 46. Asia-Pacific Liraglutide Injection Sales by Region (2016-2021e) & (K Pcs)
Table 47. Asia-Pacific Liraglutide Injection Sales by Region (2021-2026) & (K Pcs)
Table 48. Asia-Pacific Liraglutide Injection Revenue by Region (2016-2021e) & (USD Million)
Table 49. Asia-Pacific Liraglutide Injection Revenue by Region (2021-2026) & (USD Million)
Table 50. Asia-Pacific Liraglutide Injection Sales by Type (2016-2021e) & (K Pcs)
Table 51. Asia-Pacific Liraglutide Injection Sales by Type (2021-2026) & (K Pcs)
Table 52. Asia-Pacific Liraglutide Injection Sales by Application (2016-2021e) & (K Pcs)
Table 53. Asia-Pacific Liraglutide Injection Sales by Application (2021-2026) & (K Pcs)
Table 54. South America Liraglutide Injection Sales by Country (2016-2021e) & (K Pcs)
Table 55. South America Liraglutide Injection Sales by Country (2021-2026) & (K Pcs)
Table 56. South America Liraglutide Injection Revenue by Country (2016-2021e) & (USD Million)
Table 57. South America Liraglutide Injection Revenue by Country (2021-2026) & (USD Million)
Table 58. South America Liraglutide Injection Sales by Type (2016-2021e) & (K Pcs)
Table 59. South America Liraglutide Injection Sales by Type (2021-2026) & (K Pcs)
Table 60. South America Liraglutide Injection Sales by Application (2016-2021e) & (K Pcs)
Table 61. South America Liraglutide Injection Sales by Application (2021-2026) & (K Pcs)
Table 62. Middle East & Africa Liraglutide Injection Sales by Country (2016-2021e) & (K Pcs)
Table 63. Middle East & Africa Liraglutide Injection Sales by Country (2021-2026) & (K Pcs)
Table 64. Middle East & Africa Liraglutide Injection Revenue by Country (2016-2021e) & (USD Million)
Table 65. Middle East & Africa Liraglutide Injection Revenue by Country (2021-2026) & (USD Million)
Table 66. Middle East & Africa Liraglutide Injection Sales by Type (2016-2021e) & (K Pcs)
Table 67. Middle East & Africa Liraglutide Injection Sales by Type (2021-2026) & (K Pcs)
Table 68. Middle East & Africa Liraglutide Injection Sales by Application (2016-2021e) & (K Pcs)
Table 69. Middle East & Africa Liraglutide Injection Sales by Application (2021-2026) & (K Pcs)
Table 70. Direct Channel Pros & Cons
Table 71. Indirect Channel Pros & Cons
Table 72. Liraglutide Injection Typical Distributors
Table 73. Liraglutide Injection Typical Customers
List of Figures
Figure 1. Liraglutide Injection Picture
Figure 2. Global Liraglutide Injection Sales Market Share by Type in 2020
Figure 3. Adult Type 2 Diabetes
Figure 4. Type II
Figure 5. Global Liraglutide Injection Sales Market Share by Application in 2020
Figure 6. Hospital
Figure 7. Clinic
Figure 8. Global Liraglutide Injection Market Size, (USD Million) & (K Pcs): 2020 VS 2021 VS 2026
Figure 9. Global Liraglutide Injection Market Size and Forecast (2016-2026) & (USD Million)
Figure 10. Global Liraglutide Injection Sales (2016-2026) & (K Pcs)
Figure 11. Global Liraglutide Injection Price by Type (2016-2026) & (USD/Pcs)
Figure 12. Global Liraglutide Injection Production Capacity (2016-2026) & (K Pcs)
Figure 13. Global Liraglutide Injection Production Capacity by Geographic Region: 2020 VS 2021
Figure 14. Liraglutide Injection Market Drivers
Figure 15. Liraglutide Injection Market Restraints
Figure 16. Liraglutide Injection Market Trends
Figure 17. Global Liraglutide Injection Sales Market Share by Manufacturer in 2020
Figure 18. Global Liraglutide Injection Revenue Market Share by Manufacturer in 2020
Figure 19. Liraglutide Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 20. Top 3 Liraglutide Injection Manufacturer (Revenue) Market Share in 2020
Figure 21. Top 6 Liraglutide Injection Manufacturer (Revenue) Market Share in 2020
Figure 22. Global Liraglutide Injection Sales Market Share by Region (2016-2026)
Figure 23. Global Liraglutide Injection Revenue Market Share by Region (2016-2026)
Figure 24. North America Liraglutide Injection Revenue (2016-2026) & (USD Million)
Figure 25. Europe Liraglutide Injection Revenue (2016-2026) & (USD Million)
Figure 26. Asia-Pacific Liraglutide Injection Revenue (2016-2026) & (USD Million)
Figure 27. South America Liraglutide Injection Revenue (2016-2026) & (USD Million)
Figure 28. Middle East & Africa Liraglutide Injection Revenue (2016-2026) & (USD Million)
Figure 29. Global Liraglutide Injection Sales Market Share by Type (2016-2026)
Figure 30. Global Liraglutide Injection Revenue Market Share by Type (2016-2026)
Figure 31. Global Liraglutide Injection Price by Type (2016-2026) & (USD/Pcs)
Figure 32. Global Liraglutide Injection Sales Market Share by Application (2016-2026)
Figure 33. Global Liraglutide Injection Revenue Market Share by Application (2016-2026)
Figure 34. Global Liraglutide Injection Price by Application (2016-2026) & (USD/Pcs)
Figure 35. North America Liraglutide Injection Sales Market Share by Type (2016-2026)
Figure 36. North America Liraglutide Injection Sales Market Share by Application (2016-2026)
Figure 37. North America Liraglutide Injection Sales Market Share by Country (2016-2026)
Figure 38. North America Liraglutide Injection Revenue Market Share by Country (2016-2026)
Figure 39. United States Liraglutide Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 40. Canada Liraglutide Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 41. Mexico Liraglutide Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 42. Europe Liraglutide Injection Sales Market Share by Type (2016-2026)
Figure 43. Europe Liraglutide Injection Sales Market Share by Application (2016-2026)
Figure 44. Europe Liraglutide Injection Sales Market Share by Country (2016-2026)
Figure 45. Europe Liraglutide Injection Revenue Market Share by Country (2016-2026)
Figure 46. Germany Liraglutide Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. France Liraglutide Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. United Kingdom Liraglutide Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Russia Liraglutide Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Italy Liraglutide Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Asia-Pacific Liraglutide Injection Sales Market Share by Region (2016-2026)
Figure 52. Asia-Pacific Liraglutide Injection Sales Market Share by Application (2016-2026)
Figure 53. Asia-Pacific Liraglutide Injection Sales Market Share by Region (2016-2026)
Figure 54. Asia-Pacific Liraglutide Injection Revenue Market Share by Region (2016-2026)
Figure 55. China Liraglutide Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Japan Liraglutide Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Korea Liraglutide Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. India Liraglutide Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Southeast Asia Liraglutide Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Australia Liraglutide Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. South America Liraglutide Injection Sales Market Share by Type (2016-2026)
Figure 62. South America Liraglutide Injection Sales Market Share by Application (2016-2026)
Figure 63. South America Liraglutide Injection Sales Market Share by Country (2016-2026)
Figure 64. South America Liraglutide Injection Revenue Market Share by Country (2016-2026)
Figure 65. Brazil Liraglutide Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Argentina Liraglutide Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Middle East & Africa Liraglutide Injection Sales Market Share by Type (2016-2026)
Figure 68. Middle East & Africa Liraglutide Injection Sales Market Share by Application (2016-2026)
Figure 69. Middle East & Africa Liraglutide Injection Sales Market Share by Country (2016-2026)
Figure 70. Middle East & Africa Liraglutide Injection Revenue Market Share by Country (2016-2026)
Figure 71. Turkey Liraglutide Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Egypt Liraglutide Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Saudi Arabia Liraglutide Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. South Africa Liraglutide Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Sales Channel: Direct Channel vs Indirect Channel
Figure 76. Methodology
Figure 77. Research Process and Data Source
世界のプロポフォール中鎖・長鎖脂肪エマルジョン注射市場 2021：企業別、地域別、種類・用途別 The Propofol Medium and Long Chain Fat Emulsion Injection market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value cha…- 世界のガソリン直噴（GDI）市場 2021：企業別、地域別、種類・用途別 The Gasoline Direct Injection (GDI) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade…
- 世界の造影剤注入ライン市場 2021：企業別、地域別、種類・用途別 The Contrast Injection Lines market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regula…
- 世界の粉末射出成形（PIM）市場 2021：企業別、地域別、種類・用途別 The Powder Injection Molding(PIM) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade r…
- 世界のインジェクションマニピュレーター市場 2021：企業別、地域別、種類・用途別 The Injection Manipulator market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulatio…